ZLD — Zelira Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Australia Stock Exchange release from ZELIRA THERAPEUT : Application for quotation of securities - ZLD
Australia Stock Exchange release from ZELIRA THERAPEUT : Final Director's Interest Notice
Australia Stock Exchange release from ZELIRA THERAPEUT : Initial Director's Interest Notice
Australia Stock Exchange release from ZELIRA THERAPEUT : Board Changes
Australia Stock Exchange release from ZELIRA THERAPEUT : PRE_NR Ends: 08:20:40
Australia Stock Exchange release from ZELIRA THERAPEUT : Appendix 4C Cash Flow Report
Australia Stock Exchange release from ZELIRA THERAPEUT : December 2021 Quarterly Activities Report
Australia Stock Exchange release from ZELIRA THERAPEUT : PRE_NR Ends: 08:19:55
Australia Stock Exchange release from ZELIRA THERAPEUT : Notification of cessation of securities - ZLD
Australia Stock Exchange release from ZELIRA THERAPEUT : Application for quotation of securities - ZLD
Australia Stock Exchange release from ZELIRA THERAPEUT : Results of Meeting
Australia Stock Exchange release from ZELIRA THERAPEUT : 2021 Annual General Meeting Presentation
Australia Stock Exchange release from ZELIRA THERAPEUT : Zelira receives $1.2 million cash R&D Tax Incentive
Australia Stock Exchange release from ZELIRA THERAPEUT : PRE_NR Ends: 09:32:09
Australia's Zelira Therapeutics jumps on partial receipt of license fee
Australia Stock Exchange release from ZELIRA THERAPEUT : PRE_NR Ends: 09:00:14
Australia Stock Exchange release from ZELIRA THERAPEUT : Partial Receipt Of Zeliras EDCDM Technology License Fee
Australia Stock Exchange release from ZELIRA THERAPEUT : ZLDs Phase 1 pain trial published in peer-reviewed journal
Brief: Zelira Therapeutics Expands Into NZ Via Exclusive Distribution Agreement